1Cunningham D, Zaleberg J, Maroun J, et al. Efficacy, tolerability and management of raltitrexed ( Tomudex ( TM ) ) monotherapy in patients with adw3nced colorectal cancer: a review of phase Ⅱ/Ⅲ trials [J]. European Journal of Cancer, 2002, 38(4): 478. 被引量：1
2Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and eetuximab plus irinotecan in irinotecan-re- fractory metastatic coloreetal eancer[J]. N Engl J Med, 2004, 351(4): 337. 被引量：1
3Aschele C, Baldo C, Sobrero A F, et al. Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro[J]. Clinical cancer research, 1998, 4(5): 1323. 被引量：1
4Chiara S, Nobile M T, Tomasello L, et al. Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced col- orectal cancer [J]. Anticancer research, 2005, 25 ( 2B ) : 1391. 被引量：1
5Feliu J, Salud A, Escudero P, et al. Irinoteean plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study[J]. British journal of cancer, 2004, 90(8): 1502. 被引量：1
3Hagner N, Joerger M. Cancer chemotherapy:targeting folic acid syntheses[J]. Cancer Manag Res, 2010, 19(2): 1211-1222. 被引量：1
4Jarmula A. Antifolate inhibitors of thymidylate synthase as antieancer drugs[J]. Mini Rev Med Chem, 2010, 10(13): 293-301. 被引量：1
5Wilson KS, Malfair Taylor SC. Raltitrexed:optimism and reality[J]. Expert Opin Drug MetabToxicol, 2009, 5(11): 1447-1454. 被引量：1
6Kelly C, Bhuva N, Harrison M, et al.Use ofraltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history[J]. Eur J Cancer, 2013, 49(10): 2303-2310. 被引量：1
7CunninghamD, ZalcbergJR, Rathll, et al. Final results of a randomized trial comparing'Tomudex' (raltitrexed) with 5-fluorouraeil plus leucovorin in advanced colorectal cancer [J]. Ann Oneol, 1996, 7(9): 961-965. 被引量：1
8Vieitez J M, ValladaresM, PelaezI, et al. A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer[J]. Invest New Drugs, 2011, 29(5): 1038-1044. 被引量：1
9Vyzula R, Kocakova I, Demlova R, et al. Rltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer [J]. Neoplasma, 2006, 53(2): 119-127. 被引量：1
10Comella P, Casaretti R, Cmcitta E. Oxaliplatin plus raltitrexed and 5-fuorouracil I,v. bolus:a salvage regimen for colorectal Cancer patients[J]. Br J Cancer, 2002, 86(12): 1871-1875. 被引量：1
